Probiotics as a Treatment for Infantile Colic
This paper examines the use of probiotic therapy — particularly Lactobacillus reuteri — as an alternative treatment for infantile colic, a behavioral condition affecting up to 28% of infants in the first three months of life. The paper describes the disease process and its uncertain etiology, outlines standard dosing conventions for probiotics, and reviews multiple clinical studies demonstrating significant reductions in crying time among colicky breastfed infants treated with L. reuteri compared to simethicone or placebo. It also addresses reported adverse reactions, potential drug interactions, the theoretical basis for probiotic efficacy, and patient education considerations regarding FDA regulation of dietary supplements.
- Introduction to Infantile Colic: Definition, symptoms, causes, and current treatments
- Probiotic Therapy and Reported Benefits: Clinical studies on L. reuteri and colic reduction
- Possible Adverse Reactions: Known side effects and rare serious events
- Interaction with Other Medications or Treatments: Drug interactions and prescriber guidance
- Theoretical Basis for Probiotic Use: Gut microflora balance and immune system rationale
- Evidence-Based Practice Recommendations and Patient Education: Research guidance and FDA regulation context
- Conclusions: Argument for broader probiotic use in colic
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper grounds its argument in multiple peer-reviewed clinical studies, including a randomized prospective trial comparing L. reuteri directly to simethicone, lending credibility to its alternative-medicine claim.
- It balances advocacy for probiotic use with an honest discussion of adverse reactions, drug interactions, and gaps in FDA regulation, demonstrating academic fairness.
- The inclusion of a mechanistic explanation — involving toll-like receptors, cytokines, and neuroimmune pathways — elevates the paper beyond anecdote and shows engagement with the underlying science.
Key academic technique demonstrated
The paper demonstrates effective use of evidence synthesis: rather than relying on a single study, it sequences multiple studies (Savino et al. 2004, Savino et al. 2007, Romano et al. 2010) to build a cumulative case, showing how findings across different populations and methodologies converge on a consistent conclusion about L. reuteri's efficacy for infantile colic.
Structure breakdown
The paper opens with a clinical description of infantile colic and its uncertain etiology, then transitions to the intervention (probiotic therapy), reviews supporting clinical evidence, addresses safety and drug interactions, explains the theoretical mechanism, and closes with evidence-based practice recommendations and a patient education section. This disease-to-treatment structure is standard for clinical or pharmacological papers and guides the reader logically from problem to proposed solution.
Introduction to Infantile Colic
Infantile colic is a very common problem within the first three months of life. It affects as many as three percent to twenty-eight percent of infants and is characterized by a behavioral condition distinguished by spastic, extreme, inconsolable crying without a particular reason (Savino, Pelle, Palumeri, Oggero, & Miniero, 2007). Colic is often described as crying and tremendous irritability in babies. The fits of inconsolable crying often occur in the evening, though many babies do not follow a predictable pattern. The crying and fussiness can go on for hours at a time, followed by periods when the infant appears completely content. Colic is extremely common and affects approximately one in four infants. The cause of the irritability is not completely understood but may involve underdevelopment of the infant's nervous system, sleep disturbances, sensitivity to surroundings, and sensory overstimulation. Only a small portion of colicky infants will actually be affected by specific medical conditions such as gastroesophageal reflux or food allergies. These alternative possibilities should be discussed with a healthcare provider before a diagnosis of colic is made (Infantile Colic, n.d.).
Colic typically follows the rule of threes: crying begins by three weeks of age, lasts for at least three hours a day, and occurs for at least three days a week. The colicky infant will begin crying as loudly as possible, appearing to be in obvious pain, often turning red in the face, kicking the legs, arching the back, and passing gas. Occasionally, feeding will momentarily stop the crying, only for it to resume afterward. Despite these symptoms, colicky babies continue to gain weight and grow normally (Infantile Colic, n.d.).
The cause of colic is not known. Researchers have explored a variety of possibilities, including allergies, lactose intolerance, an undeveloped digestive system, maternal anxiety, and differences in the way an infant is fed or comforted. Thus far, it remains unclear why some infants develop colic and others do not (Colic, 2010).
There is currently no specific treatment, but much can be done to reduce the impact on parents of this exhausting condition. Frequently, the baby's formula is changed to a hypoallergenic variety. Some mothers adjust their own diets, eliminating gas-producing foods or dairy products. If acid reflux is suspected, antacids may be tried and continued if they provide clear benefit. In most cases, what is required is a great deal of patience. Parents and other family members should take turns caring for the baby. Infant massage, calming music, and swaddling can all help in caring for a colicky baby (Colic, 2010).
Create your account
Always verify citation format against your institution’s current style guide requirements.